<?xml version="1.0" encoding="UTF-8"?>
<ProteinModifications>
	<Entry>
		<Id>0001</Id>
		<Description>a protein modification that effectively forms a O3-xylosylserine.</Description>
		<SystematicName>(S)-2-amino-3-(alpha-D-xylopyranosyloxy)propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0406</Id>
			<Name>O-xylosyl-L-serine</Name>
			<Status>deprecated</Status>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00814</Id>
			<Name>O-xylosyl-L-serine</Name>
		</CrossReference>
		<Formula>C 8 H 13 N 1 O 6</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SER</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">XYS</Id>
			</Component>
			<Bond>
				<Atom component="1">OG</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0002</Id>
		<Description>A protein modification that effectively converts an L-asparagine residue to an N4-glycosyl-L-asparagine.</Description>
		<SystematicName>(S)-2-amino-4-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)amino-4-oxobutanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0151</Id>
			<Name>N4-(N-acetylamino)glucosyl-L-asparagine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00160</Id>
			<Name>N4-glycosyl-L-asparagine</Name>
		</CrossReference>
		<Formula>C 12 H 19 N 3 O 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">ASN</Id>
			</Component>			
			<Component type="Ligand" label="2">
				<Id source="PDBCC">NAG</Id>
			</Component>
			<Bond>
				<Atom component="1">ND2</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0003</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-phospho-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-(phosphonosulfanyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSP</Id>
			<Name>S-PHOSPHOCYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0034</Id>
			<Name>S-phospho-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00043</Id>
			<Name>S-phospho-L-cysteine</Name>
		</CrossReference>
		<Formula>C 3 H 6 N 1 O 4 P 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0004</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to tele-phospho-L-histidine (Ntau-phospho-L-histidine, 1'-phospho-L-histidine).</Description>
		<SystematicName>(S)-2-amino-3-(1-phosphono-1H-imidazol-4-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>NEP</Id>
			<Name>N1-PHOSPHONOHISTIDINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0035</Id>
			<Name>1'-phospho-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00044</Id>
			<Name>1'-phospho-L-histidine</Name>
		</CrossReference>
		<Formula>C 3 H 6 N 1 O 4 P 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">NEP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0005</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to pros-phospho-L-histidine (Npi-phospho-L-histidine, 3'-phospho-L-histidine).</Description>
		<SystematicName>(S)-2-amino-3-(3-phosphono-3H-imidazol-4-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>HIP</Id>
			<Name>ND1-PHOSPHONOHISTIDINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0036</Id>
			<Name>3'-phospho-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00045</Id>
			<Name>3'-phospho-L-histidine</Name>
		</CrossReference>
		<Formula>C 6 H 8 N 3 O 4 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HIP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0006</Id>
		<Description>A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.</Description>
		<SystematicName>(S)-2-amino-3-(phosphonooxy)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>SEP</Id>
			<Name>PHOSPHOSERINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0037</Id>
			<Name>O-phospho-L-serine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00046</Id>
			<Name>O-phospho-L-serine</Name>
		</CrossReference>
		<Formula>C 3 H 6 N 1 O 5 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SEP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0007</Id>
		<Description>A protein modification that effectively converts an L-threonine residue to O-phospho-L-threonine.</Description>
		<SystematicName>(2S,3R)-2-amino-3-phosphonooxybutanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>TPO</Id>
			<Name>PHOSPHOTHREONINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0038</Id>
			<Name>O-phospho-L-threonine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00047</Id>
			<Name>O-phospho-L-threonine</Name>
		</CrossReference>
		<Formula>C 4 H 8 N 1 O 5 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TPO</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0008</Id>
		<Description>A protein modification that effectively converts an L-tyrosine residue to O4'-phospho-L-tyrosine.</Description>
		<SystematicName>(2S)-2-amino-3-(4-phosphonooxyphenyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>PTR</Id>
			<Name>O-PHOSPHOTYROSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0039</Id>
			<Name>O4'-phospho-L-tyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00048</Id>
			<Name>O4'-phospho-L-tyrosine</Name>
		</CrossReference>
		<Formula>C 9 H 10 N 1 O 5 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">PTR</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<!--Entry>
		<Id>0009</Id>
		<Description>A protein modification that effectively converts an L-glutamine residue to N-acetyl-L-glutamine.</Description>
		<SystematicName>(S)-2-acetamido-5-pentanediamic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0045</Id>
			<Name>N-acetyl-L-glutamine</Name>
			<Status>deprecated</Status>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00054</Id>
			<Name>N-acetyl-L-glutamine</Name>
		</CrossReference>
		<Formula>C 7 H 11 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GLN</Id>
				<Terminal>N</Terminal>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">ACE</Id>
			</Component>
			<Bond>
				<Atom component="1">N</Atom>
				<Atom component="2">C</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0010</Id>
		<Description>A protein modification that effectively converts an L-methionine to N-acetyl-L-methionine.</Description>
		<SystematicName>(2S)-2-acetamido-4-(methylsulfanyl)butanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0049</Id>
			<Name>N-acetyl-L-methionine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00058</Id>
			<Name>N-acetyl-L-methionine</Name>
		</CrossReference>
		<Formula>C 7 H 12 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MET</Id>
				<Terminal>N</Terminal>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">ACE</Id>
			</Component>
			<Bond>
				<Atom component="1">N</Atom>
				<Atom component="2">C</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry-->
	<Entry>
		<Id>0011</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-acetyl-L-lysine.</Description>
		<SystematicName>(2S)-2-amino-6-acetamidohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>ALY</Id>
			<Name>N(6)-ACETYLLYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0055</Id>
			<Name>N6-acetyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00064</Id>
			<Name>N6-acetyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 8 H 14 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">ALY</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0012</Id>
		<Description>A protein modification that effectively converts an L-tyrosine residue to O4'-sulfo-L-tyrosine.</Description>
		<SystematicName>(S)-2-amino-3-(4-sulfooxyphenyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>TYS</Id>
			<Name>O-SULFO-L-TYROSINE </Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0172</Id>
			<Name>O4'-sulfo-L-tyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00181</Id>
			<Name>O4'-sulfo-L-tyrosine</Name>
		</CrossReference>
		<Formula>C 9 H 9 N 1 O 5 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TYS</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0013</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-methyl-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-methylaminohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MLZ</Id>
			<Name>N-METHYL-LYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0076</Id>
			<Name>N6-methyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00085</Id>
			<Name>N6-methyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 7 H 14 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MLZ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0014</Id>
		<Description>A protein modification that effectively converts an L-arginine residue to 5-methyl-L-arginine.</Description>
		<SystematicName>(2S,5S)-2-amino-5-carbamimidamidohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>AGM</Id>
			<Name>5-METHYL-ARGININE </Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0272</Id>
			<Name>5-methyl-L-arginine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00277</Id>
			<Name>5-methyl-L-arginine</Name>
		</CrossReference>
		<Formula>C 7 H 14 N 4 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">AGM</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0015</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6,N6,N6-trimethyl-L-lysine.</Description>
		<SystematicName>(5S)-5-amino-5-carboxy-N,N,N-trimethylpentan-1-aminium</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>M3L</Id>
			<Name>N-TRIMETHYLLYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0074</Id>
			<Name>N6,N6,N6-trimethyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00083</Id>
			<Name>N6,N6,N6-trimethyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 9 H 19 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">M3L</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0016</Id>
		<Description>A protein modification that effectively converts an L-methionine residue to N-methyl-L-methionine.</Description>
		<SystematicName>(S)-2-methylamino-4-(methylsulfanyl)butanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MME</Id>
			<Name>N-METHYL METHIONINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0064</Id>
			<Name>N-methyl-L-methionine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00073</Id>
			<Name>N-methyl-L-methionine</Name>
		</CrossReference>
		<Formula>C 6 H 11 N 1 O 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MME</Id>
				<Terminal>N</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0017</Id>
		<Description>A protein modification that effectively converts an L-proline residue to 4-hydroxy-L-proline.</Description>
		<SystematicName>(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>HYP</Id>
			<Name>4-HYDROXYPROLINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0030</Id>
			<Name>4-hydroxy-L-proline</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00039</Id>
			<Name>4-hydroxy-L-proline</Name>
		</CrossReference>
		<Formula>C 5 H 7 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HYP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0018</Id>
		<Description>A protein modification that effectively cross-links two L-cysteine residues to form L-cystine.</Description>
		<SystematicName>(R,R)-3,3'-disulfane-1,2-diylbis(2-aminopropanoic acid)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0025</Id>
			<Name>L-cystine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00034</Id>
			<Name>L-cystine (cross-link)</Name>
		</CrossReference>
		<Formula>C 6 H 8 N 2 O 2 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Bond>
				<Atom component="1">S</Atom>
				<Atom component="2">S</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0019</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to L-cysteine methyl disulfide.</Description>
		<SystematicName>(R)-2-amino-3-(methyldisulfanediyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>SCH</Id>
			<Name>S-METHYL-THIO-CYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0101</Id>
			<Name>L-cysteine methyl disulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00110</Id>
			<Name>L-cysteine methyl disulfide</Name>
		</CrossReference>
		<Formula>C 4 H 7 N 1 O 1 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SCH</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0020</Id>
		<Description>A protein modification that effectively converts three L-cysteine residues and a three-iron four-sulfur cluster to tris-L-cysteinyl triiron tetrasulfide.</Description>
		<SystematicName>mu3-sulfido-tri-mu-sulfidotris(cysteinato-kappaS-iron)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0139</Id>
			<Name>tris-L-cysteinyl triiron tetrasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00148</Id>
			<Name>tris-L-cysteinyl triiron tetrasulfide</Name>
		</CrossReference>
		<Formula>C 9 Fe 3 H 12 N 3 O 3 S 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="4">
				<Id source="PDBCC">F3S</Id>
			</Component>
			<Bond>
				<Atom component="1">S</Atom>
				<Atom component="4">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="2">S</Atom>
				<Atom component="4">FE3</Atom>
			</Bond>
			<Bond>
				<Atom component="3">S</Atom>
				<Atom component="4">FE4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink3</Category>
	</Entry>
	<Entry>
		<Id>0021</Id>
		<Description>A protein modification that effectively converts four L-cysteine residues and a two-iron two-sulfur cluster to tetrakis-L-cysteinyl diiron disulfide.</Description>
		<SystematicName>tetrakis(cysteinato)-1kappaS,1kappaS,2kappaS,2kappaS-di-mu-sulfidodiiron</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0137</Id>
			<Name>tetrakis-L-cysteinyl diiron disulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00146</Id>
			<Name>tetrakis-L-cysteinyl diiron disulfide</Name>
		</CrossReference>
		<Formula>C 12 Fe 2 H 16 N 4 O 4 S 6</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FES</Id>
			</Component>
			<Bond>
				<Atom component="1">S</Atom>
				<Atom component="5">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="2">S</Atom>
				<Atom component="5">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="3">S</Atom>
				<Atom component="5">FE2</Atom>
			</Bond>
			<Bond>
				<Atom component="4">S</Atom>
				<Atom component="5">FE2</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
	</Entry>
	<Entry>
		<Id>0022</Id>
		<Description>A protein modification that effectively converts a source amino acid residue to an N-formyl-L-methionine, a natural pretranslational modification.</Description>
		<SystematicName>(S)-2-formylamino-4-(methylsulfanyl)butanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>FME</Id>
			<Name>N-FORMYLMETHIONINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0021</Id>
			<Name>N-formyl-L-methionine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00030</Id>
			<Name>N-formyl-L-methionine</Name>
		</CrossReference>
		<Formula>C 6 H 10 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">FME</Id>
				<Terminal>N</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0023</Id>
		<Description>A protein modification that effectively converts a source amino acid residue to an L-selenocysteine, a natural pretranslational modification.</Description>
		<SystematicName>(R)-2-amino-3-selanylpropanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSE</Id>
			<Name>SELENOCYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0022</Id>
			<Name>L-selenocysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00031</Id>
			<Name>L-selenocysteine residue</Name>
		</CrossReference>
		<Formula>C 6 H 10 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSE</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0024</Id>
		<Description>A protein modification that effectively converts an L-asparagine residue to (2S,3R)-3-hydroxyasparagine.</Description>
		<SystematicName>(2S,3R)-2-amino-3-hydroxy-4-butanediamic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>AHB</Id>
			<Name>BETA-HYDROXYASPARAGINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0026</Id>
			<Name>(2S,3R)-3-hydroxyasparagine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00035</Id>
			<Name>(2S,3R)-3-hydroxyasparagine</Name>
		</CrossReference>
		<Formula>C 4 H 6 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">AHB</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0025</Id>
		<Description>A protein modification that effectively converts an L-aspartic acid residue to (2S,3R)-3-hydroxyaspartic acid.</Description>
		<SystematicName>(2S,3R)-2-amino-3-hydroxybutanedioic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>BHD</Id>
			<Name>BETA-HYDROXYASPARTIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0027</Id>
			<Name>(2S,3R)-3-hydroxyaspartic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00036</Id>
			<Name>(2S,3R)-3-hydroxyaspartic acid</Name>
		</CrossReference>
		<Formula>C 4 H 5 N 1 O 4</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">BHD</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0026</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to 5-hydroxy-L-lysine.</Description>
		<SystematicName>(2S,5R)-2,6-diamino-5-hydroxyhexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>LYZ</Id>
			<Name>5-HYDROXYLYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0028</Id>
			<Name>5-hydroxy-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00037</Id>
			<Name>5-hydroxy-L-lysine</Name>
		</CrossReference>
		<Formula>C 6 H 12 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYZ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0027</Id>
		<Description>A protein modification that effectively converts an L-proline residue to 3-hydroxy-L-proline.</Description>
		<SystematicName>(2S,3S)-3-hydroxypyrrolidine-2-carboxylic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>HY3</Id>
			<Name>3-HYDROXYPROLINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0029</Id>
			<Name>3-hydroxy-L-proline</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00038</Id>
			<Name>3-hydroxy-L-proline</Name>
		</CrossReference>
		<Formula>C 5 H 7 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HY3</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0028</Id>
		<Description>A protein modification that effectively converts an L-glutamine residue to 2-pyrrolidone-5-carboxylic acid.</Description>
		<SystematicName>(S)-5-oxo-2-pyrrolidinecarboxylic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>PCA</Id>
			<Name>PYROGLUTAMIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0031</Id>
			<Name>2-pyrrolidone-5-carboxylic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00040</Id>
			<Name>2-pyrrolidone-5-carboxylic acid (Gln)</Name>
		</CrossReference>
		<Formula>C 5 H 6 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">PCA</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0029</Id>
		<Description>A protein modification that effectively converts an L-glutamic acid residue to L-gamma-carboxyglutamic acid.</Description>
		<SystematicName>(S)-3-amino-1,1,3-propanetricarboxylic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CGU</Id>
			<Name>GAMMA-CARBOXY-GLUTAMIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0032</Id>
			<Name>L-gamma-carboxyglutamic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00041</Id>
			<Name>L-gamma-carboxyglutamic acid</Name>
		</CrossReference>
		<Formula>C 6 H 7 N 1 O 5</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CGU</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0030</Id>
		<Description>A protein modification that effectively converts an L-aspartic acid residue to L-aspartic 4-phosphoric anhydride.</Description>
		<SystematicName>(2S)-2-amino-4-oxo-4-(phosphonooxy)butanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>PHD</Id>
			<Name>ASPARTYL PHOSPHATE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0033</Id>
			<Name>L-aspartic 4-phosphoric anhydride</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00042</Id>
			<Name>L-aspartic 4-phosphoric anhydride</Name>
		</CrossReference>
		<Formula>C 4 H 6 N 1 O 6 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">PHD</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0031</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to diphthamide.</Description>
		<SystematicName>(2R)-1-amino-4-(4-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-2-yl)-N,N,N-trimethyl-1-oxobutan-2-aminium</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DDE</Id>
			<Name>{3-[4-(2-AMINO-2-CARBOXY-ETHYL)-1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}-TRIMETHYL-AMMONIUM</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0040</Id>
			<Name>2'-[3-carboxamido-3-(trimethylammonio)propyl]-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00049</Id>
			<Name>2'-[3-carboxamido-3-(trimethylammonio)propyl]-L-histidine</Name>
		</CrossReference>
		<Formula>C 13 H 22 N 5 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DDE</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0032</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-acetyl-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-(acetylsulfanyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>SCY</Id>
			<Name>S-ACETYL-CYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0056</Id>
			<Name>S-acetyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00065</Id>
			<Name>S-acetyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 5 H 7 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SCY</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0033</Id>
		<Description>A protein modification that effectively converts a glycine residue to N-myristoylglycine.</Description>
		<SystematicName>(tetradecanoylamino)ethanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0059</Id>
			<Name>N-myristoyl-glycine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00068</Id>
			<Name>N-myristoylglycine</Name>
		</CrossReference>
		<Formula>C 16 H 30 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GLY</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">MYR</Id>
			</Component>
			<Bond>
				<Atom component="1">N</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
</ProteinModifications>